Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies.

Broadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR, Dunn WB. · 2018

Read Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. by Broadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR, Dunn WB. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5960010.txt.

Description

Broadhurst and co-authors give guidelines for system suitability and quality control samples in untargeted clinical metabolomic studies. Their tutorial review appeared in Metabolomics. Such studies use mass spectrometry to measure many metabolites at once. Quality assurance and quality control keep the data trustworthy. System suitability samples check the platform before real samples run. They reveal contamination or poor operation early.

Isotope-labelled internal standards track stability for each sample, the authors explain. Pooled quality control samples condition the platform during a study. They also measure reproducibility and correct systematic errors. Reference materials support checks across studies and laboratories. The review shows how to apply each sample type and report data quality.

Catalog record

CREATORBroadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR, Dunn WB.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE89 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5960010

Browse the full library · About the Tower of Babel